The stock opened at Rs 5790.95 and touched an intraday high and low of Rs 5846.20 and Rs 5746.80, respectively, in the session so far. Shares of the company of Divi’s Laboratories Ltd. quoted a 52-week high of Rs 6276.20 and a 52-week low of Rs 3300.00.
Total market cap of the Divi’s Laboratories Ltd. stood at Rs 152961.67 crore at the time of writing this report.
Key Financials
The company reported consolidated sales of Rs 2197.0000 crore for the quarter ended 30-Jun-2024, 7.77 per cent from previous quarter’s Rs 2382.0000 crore and 18.18 per cent from the year-ago quarter’s Rs 1859.0000 crore.
-
Stock Trading
A2Z of Stock Trading – Online Stock Trading Course
-
Stock Trading
Technical Analysis Made Easy: Online Certification Course
-
Stock Trading
Options Trading Course For Beginners
-
Stock Trading
Market 104: Options Trading: Kickstart Your F&O Adventure
-
Stock Trading
Futures Trading Made Easy: Future & Options Trading Course
-
Stock Trading
Ichimoku Trading Unlocked: Expert Analysis and Strategy
-
Stock Trading
Candlesticks Made Easy: Candlestick Pattern Course
-
Stock Trading
Stock Markets Made Easy
-
Stock Trading
Dow Theory Made Easy
-
Stock Trading
Heikin Ashi Trading Tactics: Master the Art of Trading
-
Stock Trading
Derivative Analytics Made Easy
-
Stock Trading
A2Z of Stock Market for Beginners: Stock Market Course For Beginners
-
Stock Trading
Market 101: An Insight into Trendlines and Momentum
-
Stock Trading
Commodity Markets Made Easy: Commodity Trading Course
-
Stock Trading
RSI Trading Techniques: Mastering the RSI Indicator
-
Stock Trading
Technical Analysis for Everyone – Technical Analysis Course
The net for latest quarter stood at Rs 430.0 crore, 20.79 per cent from the corresponding quarter last year.
Shareholding pattern
As of 30-Sep-2024, domestic institutional investors held 11.92 per cent stake in the company, while foreign institutional investors held 17.25 per cent and the promoters 51.89 per cent.
Valuation ratio
According to BSE data, the stock traded at a price-to-earnings multiple of 91.37 and a price-to-book ratio of 6.71. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations. Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.
Divi’s Laboratories Ltd. belongs to the Pharma – Indian industry.
